Immuno-hematological monitoring after allogeneic stem cell transplantation: a single-center, prospective study of 104 patients.

Ursula La Rocca,Walter Barberi,Arianna Di Rocco,Gianluca Giovannetti,Alessia Neri,Isabella Santilio,Daniela Carmini,Luisa Quattrocchi,Maria Gozzer,Mahnaz Shafii Bafti,Roberto Ricci,Gabriella Girelli, Robin Foà,Anna Paola Iori,Serelina Coluzzi

Blood transfusion = Trasfusione del sangue（2022）

引用 0|浏览12

暂无评分

摘要

ABO incompatibility does not represent a barrier to allogeneic HSCT. It is, however, associated with prolonged transfusion requirements. Close immunohematological monitoring, as a shared standard procedure, allows appropriate transfusion support to be provided and limits post-HSCT immuno-hematological complications.

查看译文

关键词

HSCT,immuno-hematological monitoring,ABO incompatibility

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要